Literature DB >> 33947744

Cancer Progress and Priorities: Breast Cancer.

Serena C Houghton1, Susan E Hankinson2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33947744      PMCID： PMC8104131          DOI： 10.1158/1055-9965.EPI-20-1193

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.090


× No keyword cloud information.
  383 in total

1.  Urinary concentrations of environmental phenols and their associations with breast cancer incidence and mortality following breast cancer.

Authors:  Humberto Parada; Marilie D Gammon; Hope L Ettore; Jia Chen; Antonia M Calafat; Alfred I Neugut; Regina M Santella; Mary S Wolff; Susan L Teitelbaum
Journal:  Environ Int       Date:  2019-06-19       Impact factor: 9.621

Review 2.  Breastfeeding Mode and Risk of Breast Cancer: A Dose-Response Meta-Analysis.

Authors:  Mishel Unar-Munguía; Gabriela Torres-Mejía; M Arantxa Colchero; Teresita González de Cosío
Journal:  J Hum Lact       Date:  2017-02-14       Impact factor: 2.219

3.  Retinol, vitamins A, C, and E and breast cancer risk: a meta-analysis and meta-regression.

Authors:  Hu Fulan; Jiang Changxing; Wang Yi Baina; Zhang Wencui; Lin Chunqing; Wang Fan; Li Dandan; Sun Dianjun; Wang Tong; Pang Da; Zhao Yashuang
Journal:  Cancer Causes Control       Date:  2011-07-15       Impact factor: 2.506

Review 4.  Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.

Authors: 
Journal:  Contraception       Date:  1996-09       Impact factor: 3.375

5.  Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort.

Authors:  Anika Hüsing; Renée T Fortner; Tilman Kühn; Kim Overvad; Anne Tjønneland; Anja Olsen; Marie-Christine Boutron-Ruault; Gianluca Severi; Agnes Fournier; Heiner Boeing; Antonia Trichopoulou; Vassiliki Benetou; Philippos Orfanos; Giovanna Masala; Valeria Pala; Rosario Tumino; Francesca Fasanelli; Salvatore Panico; H Bas Bueno de Mesquita; Petra H Peeters; Carla H van Gills; J Ramón Quirós; Antonio Agudo; Maria-Jose Sánchez; Maria-Dolores Chirlaque; Aurelio Barricarte; Pilar Amiano; Kay-Tee Khaw; Ruth C Travis; Laure Dossus; Kuanrong Li; Pietro Ferrari; Melissa A Merritt; Ioanna Tzoulaki; Elio Riboli; Rudolf Kaaks
Journal:  Clin Cancer Res       Date:  2017-02-28       Impact factor: 12.531

6.  Epstein-Barr virus and risk of breast cancer: a systematic review and meta-analysis.

Authors:  Mohammad Farahmand; Seyed Hamidreza Monavari; Zabihollah Shoja; Hadi Ghaffari; Mehdi Tavakoli; Ahmad Tavakoli
Journal:  Future Oncol       Date:  2019-07-25       Impact factor: 3.404

Review 7.  The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials.

Authors:  Silvana Martino; Joseph Costantino; Michelle McNabb; John Mershon; Katherine Bryant; Trevor Powles; Roberta J Secrest
Journal:  Oncologist       Date:  2004

8.  Body mass index at age 18 years and recent body mass index in relation to risk of breast cancer overall and ER/PR/HER2-defined subtypes in white women and African-American women: a pooled analysis.

Authors:  Huiyan Ma; Giske Ursin; Xinxin Xu; Eunjung Lee; Kayo Togawa; Kathleen E Malone; Polly A Marchbanks; Jill A McDonald; Michael S Simon; Suzanne G Folger; Yani Lu; Jane Sullivan-Halley; Dennis M Deapen; Michael F Press; Leslie Bernstein
Journal:  Breast Cancer Res       Date:  2018-01-22       Impact factor: 6.466

9.  Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.

Authors:  Jan Hauke; Judit Horvath; Eva Groß; Andrea Gehrig; Ellen Honisch; Karl Hackmann; Gunnar Schmidt; Norbert Arnold; Ulrike Faust; Christian Sutter; Julia Hentschel; Shan Wang-Gohrke; Mateja Smogavec; Bernhard H F Weber; Nana Weber-Lassalle; Konstantin Weber-Lassalle; Julika Borde; Corinna Ernst; Janine Altmüller; Alexander E Volk; Holger Thiele; Verena Hübbel; Peter Nürnberg; Katharina Keupp; Beatrix Versmold; Esther Pohl; Christian Kubisch; Sabine Grill; Victoria Paul; Natalie Herold; Nadine Lichey; Kerstin Rhiem; Nina Ditsch; Christian Ruckert; Barbara Wappenschmidt; Bernd Auber; Andreas Rump; Dieter Niederacher; Thomas Haaf; Juliane Ramser; Bernd Dworniczak; Christoph Engel; Alfons Meindl; Rita K Schmutzler; Eric Hahnen
Journal:  Cancer Med       Date:  2018-03-09       Impact factor: 4.452

10.  Exposure to Secondhand Smoke and Risk of Cancer in Never Smokers: A Meta-Analysis of Epidemiologic Studies.

Authors:  A-Sol Kim; Hae-Jin Ko; Jin-Hyun Kwon; Jong-Myung Lee
Journal:  Int J Environ Res Public Health       Date:  2018-09-11       Impact factor: 3.390
View more
  5 in total

1.  A Washing-Free and Easy-to-Operate Fluorescent Biosensor for Highly Efficient Detection of Breast Cancer-Derived Exosomes.

Authors:  Wenqin Chen; Yan Zhang; Kaili Di; Chang Liu; Yanyan Xia; Shijia Ding; Han Shen; Zhiyang Li
Journal:  Front Bioeng Biotechnol       Date:  2022-06-28

2.  Estrogenic Activity and Risk of Invasive Breast Cancer Among Postmenopausal Women in the Nurses' Health Study.

Authors:  Etienne X Holder; Serena C Houghton; Sylvia S Sanchez; A Heather Eliassen; Jing Qian; Elizabeth R Bertone-Johnson; Zhenhua Liu; Shelley S Tworoger; Martyn T Smith; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-04-01       Impact factor: 4.090

3.  Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells.

Authors:  Aml I Mekkawy; Nermin E Eleraky; Ghareb M Soliman; Mohamed G Elnaggar; Marwa G Elnaggar
Journal:  Pharmaceutics       Date:  2022-08-18       Impact factor: 6.525

4.  Risk Factors for Chemotherapy-Induced Peripheral Neuropathy Caused by Nanoparticle Albumin-Bound Paclitaxel in Advanced Breast Cancer.

Authors:  Qie Guo; Haonan Zhang; Xiao Li; Xianghua Quan
Journal:  Biomed Res Int       Date:  2022-09-13       Impact factor: 3.246

5.  SIPA1 Regulates LINC01615 to Promote Metastasis in Triple-Negative Breast Cancer.

Authors:  Yuan Xiang; Lingyun Feng; Hui Liu; Yuhuan Liu; Jiapeng Li; Li Su; Xinghua Liao
Journal:  Cancers (Basel)       Date:  2022-10-01       Impact factor: 6.575
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.